NCT00226434View on ClinicalTrials.gov

Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)

PHASE3CompletedINTERVENTIONAL
Enrollment

661

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
HIV InfectionTuberculosis
Interventions
PROCEDURE

Early antiretroviral treatment

The ARV treatment is started 2 weeks after the diagnosis and the start of the anti-tuberculosis treatment

PROCEDURE

Late antiretroviral treatment

The ARV treatment is started 8 weeks after the diagnosis and the start of the anti-tuberculosis treatment

Trial Locations (5)

Unknown

Calmette Hospital, Phnom Penh

Khmero-Soviet Friendship Hospital, Phnom Penh

Siem Reap Referral Hospital, Siem Reap

Provincial hospital, Svay Rieng

Provincial hospital, Takeo

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV

NCT00226434 - Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA) | Biotech Hunter | Biotech Hunter